The NHS rollout of the HIV-preventing drug regimen PrEP (pre-exposure prophylaxis) has been...
UK access to PrEP ‘indefinitely postponed’ due to Covid-19
The NHS rollout of the HIV-preventing drug regimen PrEP (pre-exposure prophylaxis) has been ‘indefinitely postponed’ due to the Covid-19 pandemic, according to iNews.
AstraZeneca’s Manufacturing Facility, North Ryde, Sydney
AstraZeneca’s manufacturing facility in North Ryde, Sydney, Australia is involved in the production and export of medicines, and has been operational for more than 60 years.
Finding a cure for HIV with ViiV Healthcare and UNC-Chapel Hill
ViiV Healthcare has announced that it will renew its partnership with the University of North Carolina at Chapel Hill. The partners have been collaborating on the search for an HIV cure since 2015, bringing together academic and pharma industry skills in their quest to eliminate the virus. Abi Millar spoke to ViiV Healthcare to find out more.
No time to waste: repurposing drugs to tackle Covid-19
There is an urgent need for safe and effective drugs to combat the escalating Covid-19 pandemic. Novel vaccines and drugs are not going to be a short-term solution to this deadly viral disease. Instead, the answer could be reusing and repurposing existing innovative medicines. Allie Nawrat explores five promising examples.
Covid-19 pandemic: a deep dive into the UK’s ACCORD programme
To accelerate drugs through the early stages of clinical development and into large-scale UK studies, the UK Government’s Covid-19 Therapeutics Taskforce has created the ACCORD programme, with BerGenBio’s bemcentinib the first drug to be fast-tracked through the scheme. The company’s Mewburn Ellis patent attorney Rob Andrews explains the promise of this drug against the novel coronavirus and why taking part in the programme is beneficial for pharma companies.
Covid-19 pandemic: investigating the treatment landscape with IFPMA
It is going to take at least a year for a Covid-19 vaccine to be available; in the meantime, drugs, both novel and repurposed, could provide a quicker alternative for the pharma industry to help resolve the ongoing novel coronavirus pandemic. In a recent virtual briefing, executives from big pharma companies discussed progress to date, while noting that the industry must be exercise caution and not promise the undeliverable.
India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.